Cargando…

A V0C detector prototype

A V0C detector prototype

Detalles Bibliográficos
Publicado:	2005
Materias:	FMD Forward Multiplicity Detector
Acceso en línea:	http://cds.cern.ch/record/975946

Ejemplares similares

The V0 detector is two disks of counters in both sides of the interaction point.
por: Grossiord, Jean-Yves
Publicado: (2006)

Details of the connector setting outside the V0C box.
por: Grossiord, Jean-Yves
Publicado: (2006)

Details of the connector(3) and central element (4) setting inside the V0C box.
por: Grossiord, Jean-Yves
Publicado: (2006)

The 96 optical fibre bundles for the transfer of the light from the V0C disk to the photo-multipliers.
por: Grossiord, Jean-Yves
Publicado: (2006)

One of the eight sectors of the V0A trigger hodoscope.
Publicado: (2005)

Two sectors of a VO prototype according to the design 2 where WLS fibres are laid along the radial edges of each scintillating element.
Publicado: (2004)

View of the inner part of the VO prototype box. The WLS fibres wrapped up in teflon strips are coupled to connectors which ensure the passage of the light outside the box and its transfer in optical fibres.
Publicado: (2004)

View of the VO prototype made of two sectors of scintillating counters. WLS fibres embedded within connectors appear in green color. Beams of optical fibres inside black sheath collect and transport the emitted light to photo-multipliers a few meters apart.
Publicado: (2004)

Volume 5 Editor’s Forward
por: Cripps, Allan W.
Publicado: (2016)

The space between leave and remain: archetypal positions of British parliamentarians on Brexit
por: Woollen, Constance
Publicado: (2021)

Welcome to the supplement on measurement of healthy ageing
por: Diaz, Theresa, et al.
Publicado: (2023)

Immune response to SARS-CoV-2 vaccination in relation to peripheral immune cell profiles among patients with multiple sclerosis receiving ocrelizumab
por: Räuber, Saskia, et al.
Publicado: (2022)

SARS-CoV-2 mRNA vaccinations fail to elicit humoral and cellular immune responses in patients with multiple sclerosis receiving fingolimod
por: Meyer-Arndt, Lil, et al.
Publicado: (2022)

Comparing humoral immune response to SARS‐CoV2 vaccines in people with multiple sclerosis and healthy controls: An Austrian prospective multicenter cohort study
por: Bsteh, Gabriel, et al.
Publicado: (2022)

Humoral immunity to SARS-CoV-2 mRNA vaccination in multiple sclerosis: the relevance of time since last rituximab infusion and first experience from sporadic revaccinations
por: König, Marton, et al.
Publicado: (2023)

Low protection from breakthrough SARS-CoV-2 infection and mild disease course in ocrelizumab-treated patients with multiple sclerosis after three mRNA vaccine doses
por: Novak, Frederik, et al.
Publicado: (2023)

UA1 prototype detector
Publicado: (1980)

A real‐world study of alemtuzumab in a cohort of Italian patients
por: Russo, Cinzia Valeria, et al.
Publicado: (2021)

HIV and lower risk of multiple sclerosis: beginning to unravel a mystery using a record-linked database study
por: Gold, Julian, et al.
Publicado: (2015)

Efficacy of subcutaneous interferon β-1a on MRI outcomes in a randomised controlled trial of patients with clinically isolated syndromes
por: De Stefano, Nicola, et al.
Publicado: (2014)

Serum neurofilament as a predictor of 10-year grey matter atrophy and clinical disability in multiple sclerosis: a longitudinal study
por: Lie, Ingrid Anne, et al.
Publicado: (2022)

How common is truly benign MS in a UK population?
por: Tallantyre, Emma Clare, et al.
Publicado: (2019)

Diagnosis and treatment of progressive multiple sclerosis: A position paper
por: Pozzilli, Carlo, et al.
Publicado: (2022)

Tobacco smoking and excess mortality in multiple sclerosis: a cohort study
por: Manouchehrinia, Ali, et al.
Publicado: (2014)

Confirmed disability progression as a marker of permanent disability in multiple sclerosis
por: Sharmin, Sifat, et al.
Publicado: (2022)

Brain age as a surrogate marker for cognitive performance in multiple sclerosis
por: Denissen, Stijn, et al.
Publicado: (2022)

A pragmatic parallel arm multi-centre randomised controlled trial to assess the effectiveness and cost-effectiveness of a group-based fatigue management programme (FACETS) for people with multiple sclerosis
por: Thomas, Sarah, et al.
Publicado: (2013)

Beam Tests of the Second Prototype of a Cherenkov Counter for the ALICE T0 Detector
por: Kaplin, V A, et al.
Publicado: (2000)

Beam Tests of First Prototype of a Cherenkov Counter for the ALICE T0 Detector
por: Kaplin, V A, et al.
Publicado: (2000)

Changes to anti-JCV antibody levels in a Swedish national MS cohort
por: Warnke, Clemens, et al.
Publicado: (2013)

Automated brain volumetrics in multiple sclerosis: a step closer to clinical application
por: Wang, C, et al.
Publicado: (2016)

A model for interrogating the clinico‐radiological paradox in multiple sclerosis: Internuclear ophthalmoplegia
por: Nij Bijvank, Jenny A., et al.
Publicado: (2021)

Evolution from a first clinical demyelinating event to multiple sclerosis in the REFLEX trial: Regional susceptibility in the conversion to multiple sclerosis at disease onset and its amenability to subcutaneous interferon beta‐1a
por: Battaglini, Marco, et al.
Publicado: (2022)

Oral ponesimod in relapsing–remitting multiple sclerosis: a randomised phase II trial
por: Olsson, Tomas, et al.
Publicado: (2014)

Survival and cause of death in multiple sclerosis: a 60-year longitudinal population study
por: Lunde, Hanne Marie Bøe, et al.
Publicado: (2017)

T cell composition and polygenic multiple sclerosis risk: A population‐based study in children
por: de Mol, Casper L., et al.
Publicado: (2021)

Spasticity treatment patterns among people with multiple sclerosis: a Swedish cohort study
por: Smith, Kelsi A, et al.
Publicado: (2023)

Complete Epstein-Barr virus seropositivity in a large cohort of patients with early multiple sclerosis
por: Abrahamyan, Sargis, et al.
Publicado: (2020)

A 60-year follow-up of the incidence and prevalence of multiple sclerosis in Hordaland County, Western Norway
por: Grytten, N, et al.
Publicado: (2016)

Hormone therapy and disease activity in Danish women with multiple sclerosis: A population‐based cohort study
por: Kopp, Tine Iskov, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_u3rks2902us7krjer68jbkto9u